Medica Group (Medica), the UK’s largest teleradiology provider and a leader in digital pathology and telemedicine, announced that it has entered into an agreement with Axon Diagnostics, a UK-based clinically led diagnostics services provider delivering radiology, teleradiology and digital pathology services to the NHS and private healthcare organisations.
This integration reflects a shared vision to accelerate innovation and expand access to high quality remote diagnostic reporting across the NHS and independent healthcare sector. As Axon joins Medica, it will also welcome its sister company, MITIS Health, whose Clinical Desktop technology supports highfidelity remote reporting valued by many NHS Trusts and Axon clients.
Medica’s extensive network of clinicians will combine with Axon’s advanced technology platform to serve over 2.5 million patients, across the majority of NHS Acute Trusts.
Medica’s extensive pool of specialist clinicians, supported by its proven clinical governance and infrastructure, will be strengthened by Axon’s innovative technology platform and workflow tools, together with the Clinical Desktop technology from MITIS. Axon’s technologies are widely recognised for their agility, user-centric design, and access to Clinical Desktop technology from MITIS that enables high-performance remote desktop access, allowing clinicians to work seamlessly and securely from any appropriate location. Axon also brings a pool of high-quality clinicians, who have earned an outstanding reputation for quality of service and responsiveness. Bringing these complementary strengths together will provide increased capacity, enabling the combined company to deliver an enhanced experience for clients and their patients across the country, at greater speed. It also means the company is well-positioned to accelerate innovation in areas such as AI-enabled reporting, workflow optimisation, and expanded diagnostic services.
Together, the organisations will offer the largest clinical reporting network in the UK, covering major diagnostic subspecialties and providing proven capacity to support routine and urgent cases, including periods of surge demand. The company will serve over 2.5 million patients across 55% of all NHS Trusts.
Both organisations remain committed to acting as trusted strategic partners to healthcare providers, offering transparency, consistency and measurable improvements in patient outcomes. As such, healthcare providers will continue to work with the same trusted teams, ensuring consistency of service while benefiting over time from the expanded capabilities of the combined organisation. Axon’s advanced reporting technology will be incorporated into Medica’s service offering through a phased integration programme, while clinicians from both organisations will have access to a broader case mix and enhanced tools as systems gradually integrate. The combined scale and streamlined workflows will also support greater efficiency and cost effectiveness for clients, aligning with NHS long term priorities. The integration of Axon into Medica will deliver a resilient, flexible service that keeps patients at the heart of every decision.
Andrew Cannon, chief executive officer of Medica Group, said: “This merger marks a significant milestone for Medica, and we are proud to welcome Axon into the Medica Group. The Axon team has built an exceptional business in a remarkably short time, earning the trust of clients through first-rate service, agility and a deep commitment to quality. Bringing Axon into Medica strengthens our position as the UK’s leading diagnostics provider. Clients will continue to receive the excellent service they rely on, now supported by greater capacity and advanced reporting technology. We look forward to building a compelling future together, driving further innovation and delivering outstanding patient care at the core of our mission.”
Rahul Mehta, chief executive officer of Axon Diagnostics, said: “Axon was founded to push the boundaries of diagnostic innovation, and joining Medica enables us to amplify that mission. This merger combines our technology and agile approach with Medica’s scale and clinical excellence, meaning more patients will benefit from faster and smarter reporting. We’re excited to enter this next chapter together, bringing our teams and clients with us into the Medica Group as we continue building trusted, high quality diagnostic services.”
Medica and Axon are currently implementing a phased integration plan that will bring together systems, teams and best practices in a structured and transparent way.
Medica Group is the UK’s largest telemedicine diagnostics provider, delivering expert teleradiology and telepathology services to over half of NHS hospitals nationwide. With more than 20 years’ experience in remote diagnostics, Medica provides 24/7 coverage for urgent and routine imaging via a network of 800+ specialist clinicians across the UK, Ireland and the US. Its innovative platforms and use of AI-enhanced workflows help healthcare providers reduce imaging backlogs and improve patient outcomes. Headquartered in Hastings, UK, Medica Group also encompasses Medica Ireland (managed radiology and pathology services in Ireland) and RadMD in the USA (clinical trial imaging), underscoring its international reach and commitment to “improving lives through excellence in diagnostics and research.”
Axon Diagnostics offers a suite of solutions to support the needs of modern diagnostic imaging services, underpinned by innovative, secure streaming technology that enables efficient reporting, supports clinicians, and delivers tangible benefits for patient care.
MITIS Health is a UK-based technology provider focused on improving diagnostic workflows. MITIS Health has built the Next Generation Home and inHospital Reporting Solution for Radiology, Pathology and Clinical Desktops. The company’s Secure Gateway allows clinicians working remotely to securely project a desktop located in the hospital or datacentre, directly to any appropriate remote location. Complete lossless transmission/zero degradation of images is supported for all light-based scans such as: Plain Film, CT, MRI, PET, Ultrasound and Histopathology.